Literature DB >> 6895382

Failure to cleave measles virus fusion protein in lymphoid cells.

R S Fujinami, M B Oldstone.   

Abstract

The host-directed cleavage of measles virus fusion protein on infected lymphoid cells was studied to understand the mechanism of viral persistence in lymphoid cells in vivo. Several lymphoblastoid cell lines were infected with measles virus, and the viral glycoproteins expressed on the cell's surface were radiolabeled and analyzed for cleavage of fusion (F(0)) to F(1) by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Daudi and Ramos lymphoblastoid cells were deficient in their ability to cleave measles virus fusion protein and correspondingly produced low titers of infectious measles virus, Daudi cells being more defective than Ramos cells. In contrast, other lymphoblastoid cells studied, Victor, Raji, Wi-L2, RPMI 8866, and Seraphine, cleaved the fusion polypeptide and made significantly more infectious virus. Despite their defect in cleaving F protein, Daudi cells were able to assemble and release (noninfectious) measles virus particles into the fluid phase. The deficit in Daudi cells was corrected by fusing infected Daudi cells with cleavage-competent cells such as Victor or Raji. Furthermore, the cleavage event performed by competent cells could be mimicked at the plasma membrane by treating infected Daudi cells with trypsin, implicating the role of a plasma membrane enzyme in cleaving F(0) to F(1) during measles virus infection. Hence, lymphoid cells deficient in the plasma membrane enzyme required to cleave F protein are permissive for measles virus, maintain viral gene products, produce mostly noninfectious virus, and fail to place the biologic activity F(1) protein on their surfaces.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6895382      PMCID: PMC2186533          DOI: 10.1084/jem.154.5.1489

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  26 in total

1.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

2.  Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells.

Authors:  M Homma; M Ouchi
Journal:  J Virol       Date:  1973-12       Impact factor: 5.103

3.  Trypsin action on the growth of Sendai virus in tissue culture cells. II. Restoration of the hemolytic activity if L cell-borne Sendai virus by trypsin.

Authors:  M Homma
Journal:  J Virol       Date:  1972-05       Impact factor: 5.103

4.  Trypsin action on the growth of Sendai virus in tissue culture cells. I. Restoration of the infectivity for L cells by direct action of tyrpsin on L cell-borne Sendai virus.

Authors:  M Homma
Journal:  J Virol       Date:  1971-11       Impact factor: 5.103

5.  Cell to cell transmission of virus in the central nervous system. I. Subacute sclerosing panencephalitis.

Authors:  Y Iwasaki; H Koprowski
Journal:  Lab Invest       Date:  1974-08       Impact factor: 5.662

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Isolation of measles virus from cell cultures of brain from a patient with subacute sclerosing panencephalitis.

Authors:  F E Payne; J V Baublis; H H Itabashi
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

8.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

9.  Subacute sclerosing panencephalitis: isolation of suppressed measles virus from lymph node biopsies.

Authors:  L Horta-Barbosa; R Hamilton; B Wittig; D A Fuccillo; J L Sever; M L Vernon
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

Review 10.  Antibody-mediated destruction of virus-infected cells.

Authors:  J G Sissons; M B Oldstone
Journal:  Adv Immunol       Date:  1980       Impact factor: 3.543

View more
  13 in total

1.  Differential cytopathology and kinetics of measles oncolysis in two primary B-cell malignancies provides mechanistic insights.

Authors:  Bella Patel; Aditi Dey; Ehsan Ghorani; Shaji Kumar; Yogeshkumar Malam; Lena Rai; Andrew J Steele; Jennifer Thomson; R Gitendra Wickremasinghe; Yu Zhang; Anna Z Castleton; Adele K Fielding
Journal:  Mol Ther       Date:  2011-03-22       Impact factor: 11.454

2.  Inactivation of viruses in bubbling processes utilized for personal bioaerosol monitoring.

Authors:  I E Agranovski; A S Safatov; A I Borodulin; O V Pyankov; V A Petrishchenko; A N Sergeev; A P Agafonov; G M Ignatiev; A A Sergeev; V Agranovski
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

3.  Modulation of immune system function by measles virus infection: role of soluble factor and direct infection.

Authors:  R S Fujinami; X Sun; J M Howell; J C Jenkin; J B Burns
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

4.  Monoclonal antibodies against five structural components of measles virus. II. Characterization of five cell lines persistently infected with measles virus.

Authors:  H Sheshberadaran; E Norrby; K W Rammohan
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Proteolytic cleavage of the fusion protein but not membrane fusion is required for measles virus-induced immunosuppression in vitro.

Authors:  A Weidmann; A Maisner; W Garten; M Seufert; V ter Meulen; S Schneider-Schaulies
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Intracellular processing of measles virus fusion protein.

Authors:  T A Sato; T Kohama; A Sugiura
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

Review 7.  Physical and chemical methods for enhancing rapid detection of viruses and other agents.

Authors:  J H Hughes
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

8.  Vaccination to prevent persistent viral infection.

Authors:  M B Oldstone; A Tishon; M Eddleston; J C de la Torre; T McKee; J L Whitton
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

9.  Persistent infection of Friend erythroleukemia cells with vaccinia virus.

Authors:  B G Pogo; C Friend
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

10.  Persistence of virulent canine distemper virus in lymphoblastoid cell lines.

Authors:  J M Friedlander; B A Summers; M J Appel
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.